Syntrophin (SNT) (SNT)

Syntrophins are a family of intracellular peripheral membrane proteins that serve as critical scaffolding adapters within the dystrophin-associated glycoprotein complex (DAGC) [1]. They are characterized by a conserved domain architecture including a PDZ domain, two Pleckstrin homology (PH) domains, and a C-terminal Syntrophin Unique (SU) domain, which facilitate the recruitment of various signaling molecules to the cell membrane [2]. In skeletal and cardiac muscle, alpha-1-syntrophin (SNTA1) is particularly important for anchoring neuronal nitric oxide synthase (nNOS) and the cardiac sodium channel Nav1.5, thereby regulating local signaling and electrical excitability [3]. Mutations in syntrophin genes, specifically SNTA1, have been linked to Long QT syndrome type 12 (LQT12) due to the disruption of sodium channel regulation [3]. Furthermore, the loss of syntrophins from the sarcolemma is a hallmark of Duchenne muscular dystrophy, contributing to the loss of membrane integrity and signaling dysfunction [2]. While no drugs currently target syntrophins directly, they are significant subjects of research for gene therapy and small-molecule stabilization of the dystrophin complex [4]. Their role in anchoring aquaporin-4 (AQP4) in the brain also makes them relevant to studies on cerebral edema and blood-brain barrier function [5].

Other names

Alpha-1-syntrophinBeta-1-syntrophinBeta-2-syntrophinGamma-1-syntrophinGamma-2-syntrophinSNTA1SNTB1SNTB2SNTG1SNTG2Syntrophin family

Syntrophins function as molecular scaffolds that recruit and anchor signaling proteins, such as neuronal nitric oxide synthase (nNOS) and the voltage-gated sodium channel Nav1.5, to the dystrophin-associated glycoprotein complex (DAGC) at the sarcolemma [1][2]. By organizing these signaling microdomains via their PDZ domains, they regulate nitric oxide production and cardiac sodium current kinetics [3].